Functions for proteinases in the ovulatory process

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1751, Issue 1, 2005, Pages 95-109

  Ohnishi, Junji ^a,b   Ohnishi, Eriko ^a,b   Shibuya, Hiroshi ^a   Takahashi, Takayuki ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

ADAMTS; BMP 1 mTld; Cathepsin L; MMP; Ovulation; PA plasmin

Indexed keywords

CATHEPSIN; DISINTEGRIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; METALLOPROTEINASE DOMAIN WITH THROMBOSPONDIN MOTIF; PLASMIN; PLASMINOGEN ACTIVATOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROCOLLAGEN C PROTEINASE; PROTEINASE; STROMELYSIN; UNCLASSIFIED DRUG;

CONFERENCE PAPER; ENZYME ANALYSIS; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; FEMALE GENITAL SYSTEM; GENE DELETION; HUMAN; NONHUMAN; OOCYTE; OVULATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

MAMMALIA;

EID: 22844439757     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2005.05.002     Document Type: Conference Paper

References (185)

1. A.N. Hirshfield Development of follicles in the mammalian ovary Int. Rev. Cytol. 124 1991 43 101
2. R.L. Robker, and J.S. Richards Hormonal control of the cell cycle in ovarian cells: proliferation versus differentiation Biol. Reprod. 59 1998 476 482
3. T.J. Acosta, and A. Miyamoto Vascular control of ovarian function: ovulation, corpus luteum formation and regression Anim. Reprod. Sci. 82-83 2004 127 140
4. C. Tamanini, and M.D. Ambrogi Angiogenesis in developing follicle and corpus luteum Reprod. Dom. Anim. 39 2004 206 216
5. M.F. Smith, W.A. Ricke, L.J. Bakke, M.P.D. Dow, and G.W. Smith Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors Mol. Cell. Endocrionol. 191 2002 45 56
6. T. Ny, P. Wahlberg, and I.J.M. Brändström Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase system Mol. Cell. Endocrinol. 187 2002 29 38
7. E.A. McGee, and A.J. Hsueh Initial and cyclic recruitment of ovarian follicles Endocr. Rev. 21 2000 200 214
8. G.F. Erickson, and S. Shimasaki The physiology of folliculogenesis: the role of novel growth factors Fertil. Steril. 76 2001 943 949
9. J.E. Fortune, G.M. Rivera, and M.Y. Yang Follicular development: the role of the follicular microenvironment in selection of the dominant follicle Anim. Reprod. Sci. 82-83 2004 109 126
10. J.S. Richards, D.L. Russell, R.L. Robker, M. Dajee, and T.N. Alliston Molecular mechanisms of ovulation and luteinization Mol. Cell. Endocrinol. 145 1998 47 54
11. J.S. Richards, D.L. Russel, S. Ochsner, M. Hsieh, K.H. Doyle, A.E. Falender, Y.K. Lo, and S.C. Sharma Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization Recent Prog. Horm. Res. 57 2002 195 220
12. M. Conti Specificity of the cyclic adenosine 3′, 5′-monophosphate signal in granulosa cell function Biol. Reprod. 67 2002 1653 1661
13. J.S. Richards New signaling pathways for hormones and cyclic adenosine 3′, 5′-monophosphate action in endocrine cells Mol. Endocrinol. 15 2001 209 218
14. A.G. Andersen, B. Als-Nielsen, P.J. Hornnes, and L. Franch Andersen Time interval from human chorionic gonadotrophin (hCG) injection to follicular rupture Hum. Reprod. 10 1995 3202 3205
15. A. Tsafriri, and P.F. Kracier The time sequence of ovum maturation in the rat J. Reprod. Fertil. 29 1972 387 393
16. J.S. Richards, D.L. Russell, S. Ochsner, and L.L. Espey Ovulation: new dimensions and new regulators of the inflammatory-like response Annu. Rev. Physiol. 64 2002 69 92
17. M.M. Matzuk, and D.J. Lamb Genetic dissection of mammalian fertility pathways Nat. Cell Biol., Suppl. 2002 s41 s49
18. K.H. Burns, and M.M. Matzuk Minireview: genetic models for the study of gonadotropin actions Endocrinology 143 2002 2823 2835
19. W.J. Murdoch Proteolytic and cellular death mechanisms in ovulatory ovarian rupture Biol. Siganals Recept. 9 2000 102 114
20. W.J. Murdoch, and A.C. McDonnel Roles of the ovarian surface epithelium in ovulation and carcinogenesis Reproduction 123 2002 743 750
21. A. Salustri, A. Camaioni, M.D. Giacomo, C. Fulop, and V.C. Hascall Hyaluronan and proteoglycans in ovarian follicles Hum. Reprod. Update 5 1999 293 301
22. J. Robert, E. Fraser, T.C. Laurent, and Hyaluronan Extracellular matrix W.D. Comper Hyaluronan 1996 Harwood Academic Publishers Amsterdam 141 199
23. A.J. Fosang, and T.E. Hardingham Matrix proteoglycans W.D. Comper Extracellular Matrix 1996 Harwood Academic Publishers Amsterdam 200 229
24. L. Zhuo, M. Yoneda, M. Zhao, W. Yingsung, N. Yoshida, Y. Kitagawa, K. Kawamura, T. Suzuki, and K. Kimata Defect in SHAP-hyaluronan complex causes sever female infertility. A study of inactivation of the bikunin gene in mice J. Biol. Chem. 276 2001 7693 7696
25. C. Fülöp, S. Szánto, D. Mukhopadhyay, T. Bárdos, R.V. Kamath, M.S. Rugg, A.J. Day, A. Salustri, V.C. Hascall, T.T. Glant, and K. Mikecz Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice Development 130 2003 2253 2261
26. C.E. Brinckerhoff, and L.M. Matrisian Matrix metalloproteinases: a tale of a frog that became a prince Nat. Rev., Mol. Cell Biol. 3 2002 207 214
27. M.D. Sternlicht, and Z. Werb How matrix metalloproteinases regulate cell behavior Annu. Rev. Cell Dev. Biol. 17 2001 463 516
28. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev., Cancer 2 2002 161 174
29. C.M. Overall, and C. López-Otín Strategies for MMP inhibition in cancer: innovations for the post-trial era Nat. Rev., Cancer 2 2002 657 672
30. L. McCawley, and L.M. Matrisian Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13 2001 534 540
31. B.E. Turk, L.L. Huang, E.T. Piro, and L.C. Cantley Determination of protease cleavage site motifs using mixture-based oriented peptide libraries Nat. Biotech. 19 2001 661 667
32. C. López-Otin, and C.M. Overall Protease degradomics: a new challenge for proteomics Nat. Rev., Mol. Cell Biol. 3 2002 509 519
33. E.M. Tam, C.J. Morrison, Y.I. Wu, M.S. Stack, and C.M. Overall Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates Proc. Natl. Acad. Sci. U. S. A. 101 2004 6917 6922
34. A. Boire, L. Covic, A. Agarwal, S. Jacques, S. Sherifi, and A. Kuliopulos PAR1 is a matrix metalloproteinase-1 receptor that promotes invasion and tumorigenesis of breast cancer cells Cell 120 2005 303 313
35. A.H. Baker, D.R. Edwards, and G. Murphy Metalloproteinase inhibitors: biological actions and therapeutic opportunities J. Cell Sci. 115 2002 3719 3727
36. R. Rodgers, H.F. Irving-Rodgers, and D.L. Russell Extracellular matrix of the developing ovarian follicle Reproduction 126 2003 415 424
37. M. Princivalle, S. Hasan, G. Hosseini, and A.I. de Agostini Anticoagulant heparan sulfate proteoglycans expression in the rat ovary peaks in preovulatory granulosa cells Glycobiology 11 2001 183 194
38. S. Oksjoki, S. Sallinen, E. Vuorio, and L. Anttila Cyclic expression of mRNA transcripts for connective tissue components in the mouse ovary Mol. Hum. Reprod. 5 1999 803 808
39. R. Reich, D. Daphna-Iken, S.Y. Chun, M. Popliker, R. Slager, B.C. Adelmann-Grill, and A. Tsafriri Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: role of eicosanoids Endocrinology 129 1991 1869 1875
40. T.E. Curry Jr., and K.G. Osteen The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle Endocr. Rev. 24 2003 428 465
41. A.C. Hägglund, A. Ny, G. Leonardsson, and T. Ny Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation Endocrinology 140 1999 4351 4358
42. K. Liu, P. Wahlberg, and T. Ny Coordinated and cell-specific regulation of membrane type matrix metalloproteinase 1 (MT1-MMP) and its substrate matrix metalloproteinase 2 (MMP-2) by physiological signals during follicular development and ovulation Endocrinology 139 1998 4735 4738
43. K. Liu, J.I. Olofsson, P. Wahlberg, and T. Ny Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum Endocrinology 140 1999 5330 5338
44. J. Ohnishi, E. Ohnishi, M. Jin, W. Hirano, D. Nakane, H. Matsui, A. Kimura, H. Sawa, K. Nakayama, H. Shibuya, K. Nagashima, and T. Takahashi Cloning and characterization of a rat ortholog of MMP-23 (matrix metalloproteinase-23), a unique type of membrane-anchored matrix metalloproteinase and conditioned switching of its expression during the ovarian follicular development Mol. Endocrinol. 15 2001 747 764
45. J. Ohnishi, E. Ohnishi, and T. Takahashi The possible involvement of matrix metalloproteinase-23 (MMP-23) activity in ovulatory processes and conditioned switching of its expression during follicular development 37th Ann. Meeting, Soc. Study Reprod., Vancouver, Canada, Biol. Reprod. Special Issue 2004 224 Abstr.
46. M. Jo, L.E. Thomas, S.E. Wheeler, and T.E. Curry Jr. Membrane type-1 matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadoptropin Biol. Reprod. 70 2003 1024 1032
47. M. Jo, and T.E. Curry Jr. Regulation of matrix metalloproteinase-19 messenger RNA expression in the rat ovary Biol. Reprod. 71 2004 1796 1806
48. T.E. Curry Jr., L. Song, and S.E. Wheeler Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat Biol. Reprod. 65 2001 855 865
49. D.L. Hulboy, L.A. Rudolph, and L.M. Matrisian Matrix metalloproteinases as mediators of reproductive function Mol. Hum. Reprod. 3 1997 27 45
50. T. Itoh, T. Ikeda, H. Gomi, S. Nakao, T. Suzuki, and S. Itohara Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice J. Biol. Chem. 272 1997 22389 22392
51. C.M. Alexander, S. Selvarajan, J. Mudgett, and Z. Werb Stromelysin-1 regulates adipogenesis during mammary gland involution J. Cell Biol. 152 2001 693 703
52. C.L. Wilson, K.J. Heppner, P.A. Labosky, B.L. Hogan, and L.M. Matrisian Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin Proc. Natl. Acad. Sci. U. S. A. 94 1997 1402 1407
53. T.H. Vu, J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D. Shapiro, R.M. Senior, and Z. Werb MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes Cell 93 1998 411 422
54. R. Masson, O. Lefebvre, A. Noel, M.E. Fahime, M.P. Chenard, C. Wendling, F. Kebers, M. LeMeur, A. Dierich, J.M. Foidart, P. Basset, and M.C. Rio In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy J. Cell Biol. 140 1998 1535 1541
55. J.M. Shipley, R.L. Wesselschmidt, D.K. Kobayashi, T.J. Ley, and S.D. Shapiro Metalloproteinase is required for macrophage-mediated proteolysis and matrix invasion in mice Proc. Natl. Acad. Sci. U. S. A. 93 1996 3942 3946
56. D. Stickens, D.J. Behonick, N. Ortega, B. Heyer, B. Hartenstein, Y. Yu, A.J. Fosang, M. Schorpp-Kistner, P. Angel, and Z. Werb Altered endochondral bone development in matrix metalloproteinase 13-deficient mice Development 131 2004 5883 5895
57. M. Inada, Y. Wang, M.H. Byrne, M.U. Rahman, C. Miyaura, C. Löpez-Otín, and S.M. Krane Critical roles for collagenase-3 (Mmp-13) in development of growth plate cartilage and in endochondral ossification Proc. Natl. Acad. Sci. U. S. A. 101 2004 17192 17197
58. K. Holmbeck, P. Bianco, J. Caterina, S. Yamada, M. Kromer, S.A. Kuznetsov, M. Mankani, P.G. Robey, A.R. Poole, I. Pidoux, J.M. Ward, and H. Birkedal-Hansen MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover Cell 99 1999 81 92
59. A.M. Pendás, A.R. Folgueras, E. Llano, J. Caterina, F. Frerard, F. Rodríguez, A. Astudillo, A. Noël, H. Birkedal-Hansen, and C. Löpez-Otín Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice Mol. Cell. Biol. 24 2004 5304 5313
60. J.D. Bartlett, E. Beniash, D.H. Lee, and C.E. Smith Decreased mineral content in MMP-20 null mouse enamel is prominent during the maturation stage J. Dent. Res. 83 2004 909 913
61. B. Dubois, B. Arnold, and G. Opdenakker Gelatinase B deficiency impairs reproduction J. Clin. Invest. 106 2000 627 628
62. K.M. Yamada Tumor jailbreak Nature 424 2003 889 890
63. K.B. Hotary, E.D. Allen, P.C. Brooks, N.S. Datta, M.W. Long, and S.J. Weiss Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix Cell 114 2003 33 45
64. H. Myöhänen, and A. Vaheri Regulation and interactions in the activation of cell-associated plasminogen Cell Mol. Life Sci. 61 2004 2840 2858
65. T.E. Petersen, M.R. Martzen, A. Ichinose, and E.W. Davie Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system J. Biol. Chem. 265 1990 6104 6111
66. P. Cameliet, and D. Collen Vascular development and disorders: molecular analysis and pathogenetic insights Kidney Int. 53 1998 1519 1549
67. P. Carmeliet, and D. Collen Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulating system Thromb. Res. 91 1998 255 285
68. W.Y. Li, S.S.N. Chong, E.Y. Huang, and T.L. Tuan Plasminogen activator/plasmin system: a major player in wound healing? Wound Repair Regen. 11 2003 239 247
69. E.F. Plow, T. Herren, A. Redlitz, L.A. Miles, and J.L. Hoover-Plow The cell biology of the plasminogen system FASEB J. 9 1995 939 945
70. V. Ellis, N. Behrendt, and K. Danø Plasminogen activation by receptor-bound urokinase, a kinetic study with both cell-associated and isolated receptor J. Biol. Chem. 266 1991 12752 12758
71. R.W. Stephens, H. Tapiovaara, T. Reisberg, J. Bizik, and A. Vaheri Alpha 2-macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells Cell Regul. 2 1991 1057 1065
72. M.V. Cubellis, P. Andreasen, P. Ragno, M. Mayer, K. Danø, and F. Blasi Accessibility of receptor-bound urokinase to type 1 plasminogen activator inhibitor Proc. Natl. Acad. Sci. U. S. A. 86 1989 4828 4832
73. V. Ellis, T.C. Wun, N. Behrendt, E. Ronne, and K. Danø Inhibition of receptor-bound urokinase by plasminogen activator inhibitors J. Biol. Chem. 265 1990 9904 9908
74. W.H. Beers Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicular wall Cell 6 1975 379 386
75. J. Ohnishi, J. Yokota, R.G.S.C. Rajapakse, E. Ohnishi, T. Kudo, S.-I. Wada, and T. Takahashi Activity of an enzyme converting single-chain tissue-type plasminogen activator to the two-chain form in preovulatory human follicular fluid Mol. Reprod. Dev. 67 2004 178 185
76. X.R. Peng, A.J.W. Hsueh, and T. Ny Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation Eur. J. Biochem. 214 1993 147 156
77. A. Smokovitis, N. Kokolis, and E. Alexaki-Tzivanidou The plasminogen activator activity is markedly increase mainly at the area of the rupture of the follicular wall at the time of ovulation Anim. Reprod. Sci. 16 1988 285 294
78. D.C. Colgin, and W.J. Murdoch Evidence for a role of the ovarian surface epithelium in the ovulatory mechanism of the sheep: secretion of urokinase-type plasminogen activator Anim. Reprod. Sci. 47 1997 197 204
79. 2-antiplasmin Endocrinology 124 1989 415 421
80. W.J. Murdoch Regulation of collagenolysis and cell death by plasmin within the formative stigma of preovulatory ovine follicles J. Reprod. Fertil. 113 1998 331 336
81. P. Carmeliet, L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. DeVos, J.J. van den Oord, D. Collen, and R.C. Mulligan Physiological consequences of loss of plasminogen activator gene function in mice Nature 368 1994 419 424
82. G. Leonardsson, X.R. Peng, K. Liu, L. Nordström, P. Carmeliet, R. Mulligan, D. Collen, and T. Ny Ovulation efficiency is reduced in mice that lack plasminogen activator function: functional redundancy among physiological plasminogen activators Proc. Natl. Acad. Sci. U. S. A. 92 1995 12446 12450
83. T.H. Bugge, M.J. Flick, C.C. Daugherty, and J.L. Degen Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction Gene. Dev. 9 1995 794 807
84. J. Romer, T.H. Bugge, C. Pyke, L.R. Lund, M.J. Flick, J.L. Degen, and K. Dano Impaired wound healing in mice with a disrupted plasminogen gene Nat. Med. 2 1996 287 292
85. L.S. Gutierrez, A. Schulman, T. Brito-Robinson, F. Noria, V.A. Ploplis, and F.J. Castellino Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1 Cancer Res. 60 2000 5839 5847
86. P. Carmeliet, L. Moons, R. Lijnen, M. Baes, V. Lemaitre, P. Tipping, A. Drew, Y. Eeckhout, S. Shapiro, F. Lupu, and D. Collen Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation Nat. Genet. 17 1997 439 444
87. S. Heymans, A. Luttun, D. Nuyens, G. Theilmeier, E. Creemers, L. Moons, G.D. Dyspersin, J.P.M. Cleutjens, M. Shipley, A. Angellilo, M. Levi, O. Nübe, A. Baker, E. Keshet, F. Lupu, J.M. Herbert, J.F.M. Smits, S.D. Shapiro, M. Baes, M. Borgers, D. Collen, M.J.A.P. Daemen, and P. Carmeliet Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure Nat. Med. 5 1999 1135 1142
88. A. Ny, G. Leonardsson, A.C. Hägglund, P. Hägglöf, V.A. Ploplis, P. Carmeliet, and T. Ny Ovulation in plasminogen-deficient mice Endocrinology 140 1999 5030 5035
89. T.G. Wolfsberg, P. Primakoff, D.G. Myles, and J.M. White ADAM, a novel family of membrane proteins containing a disintegrin and metalloproteinases domain: multipotetial functions in cell-cell and cell-matrix interactions J. Cell Biol. 131 1995 275 278
90. K. Kuno, N. Kanada, E. Nakashima, F. Fujiki, F. Ichimura, and K. Matsushima Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene J. Biol. Chem. 272 1997 556 562
91. B.L. Tang ADAMTS: a novel family of extracellular matrix proteases Int. J. Biochem. Cell Biol. 33 2001 33 44
92. S.S. Apte A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family Int. J. Biochem. Cell Biol. 36 2004 981 985
93. S. Porter, I.M. Clark, L. Kevorkian, and D.R. Edwards The ADAMTS metalloproteinases Biochem. J. 386 2005 15 27
94. J.M. White ADAMs: modulators of cell-cell and cell-matrix interactions Curr. Opin. Cell Biol. 15 2003 598 606
95. K. Kuno, and K. Matsushima ADAMTS-1 protein anchors at the extracellular matrix through the thrombospondin type I motifs and its spacing region J. Biol. Chem. 273 1998 13912 13917
96. R.P. Somerville, J.M. Longpre, K.A. Jungers, J.M. Engle, M. Ross, S. Evanko, T.N. Wight, R. Leduc, and S.S. Apte Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Cenorhbditis elegans GON-1 J. Biol. Chem. 278 2003 9503 9513
97. M.D. Tortorella, M. Pratta, R.Q. Liu, J. Austin, O.H. Ross, I. Abbaszade, T. Burn, and E.C. Arner Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4) J. Biol. Chem. 275 2000 18566 18573
98. 442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4 J. Biol. Chem. 276 2001 13372 13378
99. H. Nakamura, Y. Fujii, I. Inoki, K. Sugimoto, K. Tanzawa, H. Matsuki, R. Miura, Y. Yamaguchi, and Y. Okada Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites J. Biol. Chem. 275 2000 38885 38890
100. A.M. Malfait, R.Q. Liu, K. Ijiri, S. Komiya, and M.D. Tortorella Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage J. Biol. Chem. 277 2002 22201 22208
101. F. Vázquez, G. Hastings, M.A. Ortega, T.F. Lane, S. Oikemus, M. Lombardo, and M.L. Iruela-Arispe METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity J. Biol. Chem. 274 1999 23349 23357
102. A. Colige, S.W. Li, A.L. Sieron, B.V. Nusgens, D.J. Prockop, and C.M. Lapiere cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components Proc. Natl. Acad. Sci. U. S. A. 94 1997 2374 2379
103. A. Colige, A.L. Sieron, S.W. Li, U. Schwarze, E. Petty, W. Wertelecki, W. Wilcox, D. Krakow, D.H. Cohn, W. Reardon, P.H. Byers, C.M. Lapiere, D.J. Prockop, and B.V. Nusgens Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene Am. J. Hum. Genet. 65 1999 308 317
104. S.W. Li, M. Arita, A. Fertala, Y. Bao, GC. Kopen, T.K. Langsjo, M.M. Hyttinen, H.J. Helminen, and D.J. Prockop Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility Biochem. J. 355 2001 271 278
105. R.J. Fernandes, S. Hirohata, J.M. Engle, A. Colige, D.H. Cohn, D.R. Eyre, and S.S. Apte Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis J. Biol. Chem. 276 2001 31502 31509
106. R. Blelloch, and J. Kimble Control of organ shape by a secreted metalloprotease in the nematode Caenorhabditis elegance Nature (London) 399 1999 586 590
107. C. Rao, D. Foernzler, S.K. Loftus, S. Liu, J.D. McPherson, K.A. Jungers, S.S. Apte, W.J. Pavan, and D.R. Beier A defect in a novel ADAMTS family member is the cause of the belted white-spotting mutation Development 130 2003 4665 4672
108. X. Zheng, D. Chung, T.K. Takayama, E.M. Majerus, J.E. Sadler, and K. Fujikawa Structure of von Willebrand factor-cleaving protease (ADAMTS-13), a metallorpotease involved in thrombotic thrombocytopenic purpura J. Biol. Chem. 276 2001 41059 41063
109. R.L. Robker, D.L. Russell, L.L. Espey, J.P. Lydon, B.W. O'Malley, and J.S. Richards Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases Proc. Natl. Acad. Sci. U. S. A. 97 2000 4689 4694
110. J.S. Richards, I. Hernadez-Gonzalez, I. Gonzalez-Robayna, E. Teuling, Y. Lo, D. Boerboom, A.E. Falender, K.H. Doyle, R.G. LeBaron, V. Thompson, and J.D. Sandy Regulated expression of ADAMTS family members in follicles and cumulus oocyte complexes: evidence for specific and redundant patterns during ovulation Biol. Reprod. 72 2005 1241 1255
111. S. Cal, A.J. Obaya, M. Llamzares, C. Garabaya, V. Quesada, and C. López-Otín Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains Gene 283 2002 49 62
112. M. Llamazares, S. Cal, V. Quesada, and C. López-Otín Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinase-disintegrins with multiple thrombospondin-1 repeats and unique GON domain J. Biol. Chem. 278 2003 13382 13389
113. L.L. Espey, S. Yoshioka, D.L. Russell, R.L. Robker, S. Fujii, and J.S. Richards Ovarian expression of a disintegrin and metalloproteinase with thrombospondin motifs during ovulation in the gonadotropin-primed immature rat Biol. Reprod. 62 2000 1090 1095
114. D. Boerboom, D.L. Russell, J.S. Richards, and J. Sirios Regulation of transcripts encoding ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin-like motifs-1) and progesterone receptor by human chorionic gonadotropin in equine preovulatory follicles J. Mol. Endocrinol. 31 2003 473 485
115. K.M.H. Doyle, D.L. Russell, V. Sriraman, and J.S. Richards Coordinate transcription of the ADAMTS-1 gene by luteinizing hormone and progesterone receptor Mol. Endocrinol. 18 2004 2463 2478
116. T. Shindo, H. Kurihara, K. Kuno, H. Yokoyama, T. Wada, Y. Kurihara, T. Imai, Y. Wang, M. Ogata, H. Nishimatsu, N. Moriyama, Y. Oh-hashi, H. Morita, T. Ishikawa, R. Nagai, Y. Yazaki, and K. Matsushima ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function J. Clin. Invest. 105 2000 1345 1352
117. L. Mittaz, D.L. Russell, T. Wilson, M. Brasted, J. Tkalcevic, L.A. Salamonsen, P.J. Hertzog, and M.A. Pritchard ADAMTS-1 is essential for the development and function of the uro-genital system Biol. Reprod. 70 2004 1096 1105
118. J.T. Gallagher Heparan sulphate proteoglycans: the control of cell growth W.D. Comper Extracellular Matrix 1996 Harwood Academic Publishers Amsterdam 230 245
119. D.L. Russell, K.M. Doyle, S.A. Ochsner, J.D. Sandy, and J.S. Richards Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation J. Biol. Chem. 278 2003 42330 42339
120. B.J. Davis, D.E. Lennard, C.A. Lee, H.F. Tiano, S.G. Morham, W.C. Wetsel, and R. Langenbach Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1β Endocrinology 140 1999 2685 2695
121. S.A. Ochsner, D.L. Russell, A.J. Day, R.M. Breyer, and J.S. Richards Decreased expression of tumor necrosis factor-α-stimulated gene 6 in cumulus cells of the cyclooxygenase-2 and EP2 null mice Endocrinology 144 2003 1008 1019
122. D.L. Russell, S.A. Ochsner, M. Hsieh, S. Mulders, and J.S. Richards Hormone-regulated expression and localization of versican in the rodent ovary Endocrinology 144 2003 1020 1031
123. M.E. McArthur, H.F. Irving-Rodgers, S. Byers, and R.J. Rodgers Identification and immunolocalization of decorin, versican, perlecan, nidogen, and chondroitin sulfate proteoglycans in bovine small-antral ovarian follicles Biol. Reprod. 63 2000 913 924
124. G.V. Eriksen, I. Carlstedt, M. Morgelin, N. Uldbjoerg, and A. Malmstrom Isolation and characterization of proteoglycans from human follicular fluid Biochem. J. 340 1999 613 620
125. M. Yanagishita, and V.C. Hascall Cell surface heparan sulfate proteglycans J. Biol. Chem. 267 1992 9451 9454
126. A. Camaioni, A. Salustri, M. Yanagishita, and V.C. Hascall Proteglycans and proteins in the extracellular matrix of mouse cumulus cell-oocyte complexes Arch. Biochem. Biophys. 325 1996 190 198
127. A. Salustri, M. Yanagishita, C.B. Underhill, T.C. Laurent, and V.C. Hascall Localization and synthesis of hyaluronic acid in the cumulus cells and mural granulosa cells of the preovulatory follicle Dev. Biol. 151 1992 541 551
128. P.W. Park, O. Reizes, and M. Bernfield Cell surface heparan sulfate proeglycans: selective regulators of ligand-receptor encounters J. Biol. Chem. 275 2000 29923 29926
129. D. Brömme, P.R. Bonneau, P. Lachance, and A.C. Storer Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity J. Biol. Chem. 269 1994 30238 30242
130. F.C.V. Portaro, A.B.F. Santos, M.H.S. Cezari, M.A. Juliano, L. Juliano, and E. Carmona Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P′2 and P′3 variations in extended substrates Biochem. J. 347 2000 123 129
131. K. Ishidoh, and E. Kominami Gene regulation and extracellular functions of procathepsin L Biol. Chem. 379 1998 131 135
132. U. Felbor, L. Dreier, R.A. Bryant, H.L. Ploegh, B.R. Olsen, and W. Mothes Secreted cathepsin L generates endostatin from collagen XVIII EMBO J. 19 2000 1187 1194
133. F.M. Dehrmann, T.H.T. Coetzer, R.N. Pike, and C. Dennison Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium Arch. Biochem. Biophys. 324 1995 93 98
134. H. Kirschke, A.A. Kembhavi, P. Bohley, and A.J. Barret Action of rat liver cathepsin L on collagen and other substrates Biochem. J. 201 1982 367 372
135. O. Zwad, B. Kübler, W. Roth, J.-G. Scharf, P. Saftig, C. Peters, and T. Braulke Decreased intracellular degradation of insulin-like growth factor binding protein-3 in cathepsin L-deficient fibroblasts FEBS Lett. 510 2002 211 215
136. W. Roth, J. Deussing, V.A. Botchkarev, M. Pauly-Evers, P. Saftig, A. Hafner, P. Schmidt, W. Schmahl, J. Scherer, I. Anton-Lamprecht, K. Von Figura, R. Paus, and C. Peters Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling FASEB J. 14 2000 2075 2086
137. J. Stypmann, K. Gläser, W. Roth, D.J. Tobin, I. Petermann, R. Matthias, G. Mönnig, W. Haverkamp, G. Breithardt, W. Schmahl, C. Peters, and T. Reinheckel Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L Proc. Natl. Acad. Sci. U. S. A. 99 2002 6234 6239
138. R.C. Bunn, and J.L. Fowlkes Insulin-like growth factor binding protein proteolysis Trends Endocrinol. Metab. 14 2003 176 181
139. S. Mazerbourg, C.A. Bondy, J. Zhou, and P. Monget The insulin-like growth factor system: a key determinant role in the growth and selection of ovarian follicles? A comparative species study Reprod. Domest. Anim. 38 2003 247 258
140. T.M. Lin, S.P. Halbert, D.J. Kiefer, W.N. Spellacy, and S. Gall Characterization of four human pregnancy-associated plasma proteins Am. J. Obstet. Gynecol. 118 1974 223 236
141. C. Oxvig, O. Sand, T. Kristensen, G.J. Gleich, and L. Sottrup-Jensen Circulating human pregnancy-associated plasma protein-A is disulphide-bridged to the proform of eosinophil major basic protein J. Biol. Chem. 268 1993 12243 12246
142. M.T. Overgaard, J. Haaning, H.B. Boldt, I.M. Olsen, L.S. Laursen, M. Christiansen, G.J. Gleich, L. Sottrup-Jensen, C.A. Conover, and C. Oxvig Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor J. Biol. Chem. 275 2000 31128 31133
143. H.B. Boldt, M.T. Overgaard, L.S. Laursen, K. Weyer, L. Sottrup-Jensen, and C. Oxvig Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin Biochem. J. 358 2001 359 367
144. J.B. Lawrence, C. Oxvig, M.T. Overgaad, L. Sottrup-Jensen, G.J. Gleich, L.G. Hays, J.R. Yates III, and C.A. Conover The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A Proc. Natl. Acad. Sci. U. S. A. 96 1999 3149 3153
145. C.A. Conover, C. Oxvig, M.T. Overgaad, M. Christiansen, and L.C. Giudice Evidence that insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A J. Clin. Endocrinol. Metab. 84 1999 4742 4745
146. D. Byun, S. Mohan, M. Yoo, C. Sexton, D.J. Baylink, and X. Qin Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro J. Clin. Endocrinol. Metab. 86 2001 847 854
147. L.S. Laursen, M.T. Overgaard, R. Søe, H.B. Boldt, L. Sottrup-Jensen, L.C. Giudice, C.A. Conover, and C. Oxvig Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A FEBS Lett. 504 2001 36 40
148. G.M. Rivera, and J.E. Fortune Selection of the dominant follicle and insulin-like growth factor (IGF)-binding proteins: evidence that pregnancy-associated plasma protein A contributes to proteolysis of IGF-binding protein 5 in bovine follicular fluid Endocrinology 144 2003 437 446
149. M.T. Overgaard, H.B. Bold, L.S. Laursen, L. Sottrup-Jensen, C.A. Conover, and C. Oxvig Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase J. Biol. Chem. 276 2001 21849 21853
150. J. Baker, M.P. Hardy, J. Zhou, C. Bondy, F. Lupu, A.R. Bellve, and A. Efstratiadis Effects of an igf1 gene null mutation on mouse reproduction Mol. Endocrinol. 10 1996 903 918
151. L.J. Spicer Proteolytic degradation of insulin-like growth factor binding proteins by ovarian follicles: a control mechanism for selection of dominant follicles Biol. Reprod. 70 2004 1223 1230
152. S. Mazerbourg, M.T. Overgaard, C. Oxvig, M. Christiansen, C.A. Conover, I. Laurendeau, M. Vidaud, G. Tosser-Klopp, J. Zapf, and P. Monget Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development Endocrinology 142 2001 5243 5253
153. A. Hourvitz, A.E. Widger, F.L. Filho, R.J. Chang, E.Y. Adashi, and G.F. Erickson Pregnancy-associated plasma protein-A gene expression in human ovaries is restricted to healthy follicles and corpus lutea J. Clin. Endocrinol. Metab. 85 2000 4916 4920
154. A. Hourvits, A. Kuwahara, J.D. Hennebold, A.B. Tavares, H. Negishi, T.H. Lee, G.F. Erickson, and E.Y. Adashi The regulated expression of the pregnancy-associated plasma protein-A in the rodent ovary: a proposed role in the development of dominant follicles and of corpora lutea Endocrinology 143 2002 1833 1844
155. C.A. Conover, L.K. Bale, M.T. Overgaard, E.W. Johnstone, U.H. Laursen, E.-M. Füchtbauer, C. Oxvig, and J. van Deursen Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development Development 131 2004 1187 1194
156. T.M. DeChiara, A. Efstratiadis, and E.J. Robertson A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting Nature 345 1990 78 80
157. S. Mazerbourg, I. Callebaut, J. Zapf, S. Mohan, M. Overgaard, and P. Monget Up date on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo Growth Horm. IGF Res. 14 2004 71 84
158. J.M. Wozney, V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, R.W. Kriz, R.M. Hewick, and E.A. Wang Novel regulators of bone formation: molecular clones and activities Science 242 1988 1528 1534
159. K. Takahara, G.E. Lyons, and D.S. Greenspan Bone morphogenetic protein-1 and a mammalian tolloid homologue (mTld) are encoded by alternatively spliced transcripts which are differentially expressed in some tissues J. Biol. Chem. 269 1994 32572 32578
160. E. Kessler, K. Takahara, L. Biniaminov, M. Brusel, and D.S. Greenspan Bone morphogenetic protein-1: the type I procollagen C-proteinase Science 271 1996 360 362
161. S.-W. Li, A.L. Sieron, A. Fertala, Y. Hojima, W.V. Arnold, and D.J. Prockop The C-proteinase that processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenic protein-1 Proc. Natl. Acad. Sci. U. S. A. 93 1996 5127 5130
162. 2(V) collagen heterotrimer by bone morphogenetic protein-1 and furin-like proprotein contertases J. Biol. Chem. 277 2002 5596 5602
163. M.V. Panchenko, W.G. Stetler-Stevenson, O.V. Trubetskoy, S.N. Gacheru, and H.M. Kagan Metalloptoteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. Potential role of procollagen C-proteinase J. Biol. Chem. 271 1996 7113 7119
164. M.I. Uzel, I.C. Scott, H. Babakhanlou-Chase, A.H. Palamakumbura, W.N. Pappano, H.-H. Hong, D.S. Greenspan, and P.C. Trackman Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast culture J. Biol. Chem. 276 2001 22537 22543
165. I.C. Scott, Y. Imamura, W.N. Pappano, J.M. Troedel, A.D. Reclies, P.J. Roughley, and D.S. Greenspan Bone morphogenetic protein-1 processes probiglycan J. Biol. Chem. 275 2000 30504 30511
166. A. Rattenholl, W.N. Pappano, M. Koch, D.R. Keene, K.E. Kadler, T. Sasaki, R. Timple, R.E. Burgeson, D.S. Greenspan, and L. Bruckner-Tuderman Proteinases of the BMP-1 family convert procollagen VII to mature anchoring fibril collagen J. Biol. Chem. 277 2002 26372 26378
167. 2 chain J. Biol. Chem. 275 2000 22728 22735
168. D.P. Veitch, P. Nokelainen, K.A. McGrowan, T.T. Nguyen, R. Stephenson, W.N. Pappano, D.R. Keene, S.M. Spong, D.S. Greenspan, P.R. Findell, and M.P. Marinkovich Mammalian tolloid metalloproteinase, and not matrix metalloproteinase 2 or membrane type 1 metalloproteinase, processes laminin-5 in keratinocytes and skin J. Biol. Chem. 278 2003 15661 15668
169. E.M. Gonzalez, C.C. Reed, G. Bix, J. Fu, Y. Zhang, B. Gopalakrishnan, D.S. Greenspan, and R.V. Iozzo BMP-1/tolloid-like metalloproteinase process endorepellin, the angiostatic C-terminal fragment of perlecan J. Biol. Chem. 280 2005 7080 7087
170. N. Suzuki, P.A. Labosky, Y. Furuta, L. Hargett, R. Dunn, A.B. Fogo, K. Takahara, D.M.P. Peters, D.S. Greenspan, and B.L.M. Hogan Failure of ventral body wall closure in mouse embryos lacking a procollagene C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid Development 122 1996 3587 3595
171. W.N. Pappano, B.M. Steiglitz, I.C. Scott, D.R. Keene, and D.S. Greenspan Use of Bmp1/Tll1 double homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenic protein 1/Tolloid-like metalloproteinases Mol. Cell. Biol. 23 2003 4428 4438
172. M. Simian, Y. Hirai, M. Navre, Z. Werb, A. Lochter, and M. Bissell The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells Development 128 2001 3117 3131
173. R. Reich, A. Tsafriri, and G.L. Mechanic The involvement of collagenolysis in ovulation in the rat Endocrinology 116 1985 522 527
174. M. Brännström, J.F. Woessner Jr., R.D. Koos, C.H. Sear, and W.J. LeMaire Inhibitors of mammalian tissue collagenase and metalloproteinases suppress ovulation in the perfused rat ovary Endocrinology 122 1988 1715 1721
175. T.A. Butler, C. Zhu, R.A. Mueller, G.C. Fuller, W.J. LeMaire, and J.F. Weossner Jr. Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC44463 Biol. Reprod. 44 1991 1183 1188
176. M.L. Gottsch, E.A. Van Kirk, and W.J. Murdoch Role of matrix metalloproteinase 2 in the ovulatory folliculo-luteal transition of ewes Reproduction 124 2002 347 352
177. M. Pavlaki, and S. Zucker Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials Cancer Metastasis Rev. 22 2003 177 203
178. R.A. Wagenaar-Miller, L. Gorden, and L.M. Matrisian Matrix metalloproteinase in colorectal cancer: is it worth talking about? Cancer Metastasis Rev. 23 2004 119 135
179. C. Bremer, C.H. Tung, and R. Weissleder In vivo molecular target assessment of matrix metalloproteinase inhibition Nat. Med. 7 2001 743 748
180. R. Ala-aho, M. Ahonen, S.J. George, J. Heikkilä, R. Grénman, M. Kalljoki, and V.-M. Kähäri Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo Oncogene 23 2004 5111 5123
181. P. Stein, P. Svoboda, and R.M. Schultz Transgenic RNAi in mouse oocytes: a simple and fast approach to study gene function Dev. Biol. 256 2003 187 193
182. S. Federman, L.M. Miller, and I. Sagi Following matrix metalloproteinases activity near the cell boundary by infrared micro-spectroscopy Matrix Biol. 21 2002 567 577
183. J.O. McIntyre, B. Fingleton, K.S. Wells, D.W. Piston, C.C. Lynch, S. Gautam, and L.M. Matrisian Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumor-associated matrix metalloproteinase-7 activity Biochem. J. 377 2004 617 628
184. C.J. Jorgez, M. Klysik, S.P. Jamin, R.D. Behringer, and M.M. Matzuk Granulosa cell-specific inactivation of follistatin causes female fertility defects Mol. Endocrinol. 18 2004 953 967
185. U.M. Rose, R.G.J.M. Hanssen, and H.J. Kloosterboer Development and characterization of an in vitro ovulation model using mouse ovarian follicles Biol. Reprod. 61 1999 503 511